Search results

Evidence-based recommendations on peginterferon alfa (Pegasys; ViraferonPeg) and ribavirin for treating chronic hepatitis C in adults.

Result type

Technology appraisal guidance

Published

22 September 2010

Evidence-based recommendations on peginterferon alfa (Pegasys; ViraferonPeg) and ribavirin (Copegus) for treating chronic hepatitis C in children and young people.

Result type

Technology appraisal guidance

Published

27 November 2013

Evidence-based recommendations on peginterferon alfa (Pegasys) and ribavirin for people with mild chronic hepatitis C.

Result type

Technology appraisal guidance

Last updated

27 November 2013

Evidence-based recommendations on adefovir dipivoxil (Hepsera) and peginterferon alfa-2a (Pegasys) for treating chronic hepatitis B in adults.

Result type

Technology appraisal guidance

Published

22 February 2006

This guideline covers assessing and managing chronic hepatitis B in children, young people and adults. It aims to improve care for people with hepatitis B by specifying which tests and treatments to use for people of different ages and with different disease severities.

Result type

Clinical guideline

Last updated

20 October 2017

Topic prioritisation

Result type

Technology appraisal guidance

Status

Topic prioritisation

Evidence-based recommendations on interferon alfa (Pegasys or ViraferonPeg) and ribavirin for people with chronic hepatitis C.

Result type

Technology appraisal guidance

Last updated

27 November 2013

Evidence-based recommendations on sofosbuvir (Sovaldi) for treating some types of chronic hepatitis C (HCV)

Result type

Technology appraisal guidance

Published

25 February 2015

Evidence-based recommendations on sofosbuvir–velpatasvir (Epclusa) for treating chronic hepatitis C in adults.

Result type

Technology appraisal guidance

Published

25 January 2017

Evidence-based recommendations on ombitasvir–paritaprevir–ritonavir (also known as Viekirax) with or without dasabuvir (also known as Exviera) for adults with some types (called genotypes) of chronic hepatitis C.

Result type

Technology appraisal guidance

Published

25 November 2015

Evidence-based recommendations on ledipasvir–sofosbuvir (Harvoni) for treating some types (genotypes) of chronic hepatitis C.

Result type

Technology appraisal guidance

Published

25 November 2015

Evidence-based recommendations on entecavir for treating chronic hepatitis B in adults.

Result type

Technology appraisal guidance

Published

27 August 2008

Evidence-based recommendations on sofosbuvir–velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C in adults.

Result type

Technology appraisal guidance

Published

21 February 2018

Find out what guidance is being considered for development

Evidence-based recommendations on glecaprevir–pibrentasvir (Maviret) for treating chronic hepatitis C in adults.

Result type

Technology appraisal guidance

Published

24 January 2018